Signaling Pathways in Cancer Symposium 2012

Understanding Signaling Pathways in Cancer

Tuesday, November 6, 2012

Speakers

	Joan Brugge Harvard Medical School “Matrix Dependent Rewiring of Signaling Pathways Following Targeted Therapies” view video
	Lewis Cantley Harvard Medical School “PI 3-Kinase and Cancer Metabolism”
	Michael Comb Cell Signaling Technology “Mapping Signaling Networks in Cancer: Phosphorylation and Beyond” view video
	Rudolf Jaenisch Whitehead Institute “Stem Cells, Pluripotency and Nuclear Reprogramming” view video
	William Kaelin Dana Farber Cancer Institute “The VHL Tumor Suppressor Protein: Insights into Oxygen Sensing and Cancer Metabolism” view video
	Douglas Lauffenburger MIT Dept. of Biological Engineering “Multi-Scale In Vivo Systems Analysis of Cell Signaling in Inflammatory Pathologies” view video
	Rune Linding Technical University of Denmark “Biological Forecasting and Modeling of Cancer Kinome Networks” view video
	Benjamin Neel University Health Network “A New Role For Gab Proteins In Control Of Cell Polarity” view video
	David Sabatini Whitehead Institute “Growth By The mTOR Pathway” view video
	Jeffrey Settleman Genentech, Inc. “The Many Flavors of Resistance To Anti-Cancer Drugs” view video
	Forest White, David H. Koch Institute for Integrative Cancer Research at MIT “Connecting Genetics To Phenotype Through Quantitative Proteomics” view video
	Michael Yaffe David H. Koch Institute for Integrative Cancer Research at MIT “Harnessing Cross-Talk Between Signaling Pathways to Improve Cancer Treatment” view video